Rising Insulin Prices Highlight SPT Week in Review

5. FDA Approves Ibrutinib Combo Regimen for CLL

Ibrutinub plus obinutuzumab is the first FDA-approved non-chemotherapy combination regimen for chronic lymphocytic lymphoma and small lymphocytic lymphoma. Read more.

4. Targeted Approach Shows Promise in Treating Deadly Pediatric Brain Cancer

A targeted therapeutic approach shrank tumors caused by medulloblastoma, a deadly form a pediatric brain cancer. Read more.

3. Resource-based Approach to Pre-ART CD4 Testing Can Significantly Reduce HIV-related Mortality

Better strategies are needed to adequately identify and prevent opportunistic infections and related deaths in patients with advanced HIV. Read more.

2. Driven by Surging Prices, Patient Spend on Insulin Nearly Doubles Over 5 Years

Analysis shows prices among all insulin types and products increased steadily between 2012 and 2016. Read more.

1. Senate Hearing on Drug Prices Addresses Skyrocketing Insulin Costs

Senate Finance Committee Chairman Senator Charles Grassley pledged to “get to the bottom of the insulin price problem.” Read more.


Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Most Popular

Related Articles

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Top news of the week from Specialty Pharmacy Times.
Top news of the week from Specialty Pharmacy Times.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.